IOVA

IOVA Operating Income Growth

27.88%TTM

Period ending:

IOVA TTM Operating Income YoY %%
IOVA TTM Operating Income YoY %974.77%-8313.19%
2009-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

IOVA operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 67 observations from Dec 31, 2009 to Jun 30, 2026.

Iovance Biotherapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
27.8764%
10.2167%
-0.7425%
4.3327%
10.5859%
14.6864%
14.1743%
3.6701%
-7.2087%
-11.8185%
-15.4636%
-14.0636%
-13.5804%
-16.4904%
-16.3917%
-25.5106%
-32.5692%
-34.5519%
-30.8341%
-20.6021%
-13.2737%
-12.2009%
-26.6179%
-46.2964%
-56.8228%
-68.1411%
-61.2936%
-48.0115%
-50.1411%
-42.9798%
-38.0945%
-44.3097%
-34.4031%
-46.4532%
-73.152%
-79.0865%
-127.6743%
-128.2937%
-92.5305%
-90.5027%
-79.6115%
-96.1268%
-131.3953%
-29.8822%
-4.4733%
13.8203%
24.4715%
-202.7895%
-265.3294%
-206.8397%
-96.0039%
41.8027%
65.5977%
75.9369%
61.6693%
39.5573%
-24.3982%
-1,585.7933%
-2,502.4489%
-5,349.6446%
-7,414.3558%
-1,729.2933%
-5,069.3444%
-1,058.4873%
-490.7644%
-99.8128%
72.3976%

Compare operating income growth

All IOVA financial metrics · IOVA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.